4//SEC Filing
Miller Michael 4
Accession 0001209191-11-053340
CIK 0001333170other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:19 PM ET
Size
8.9 KB
Accession
0001209191-11-053340
Insider Transaction Report
Form 4
Miller Michael
President, International
Transactions
- Exercise/Conversion
Common Stock
2011-10-28+1,250→ 2,087 total - Exercise/Conversion
Restricted Stock Unit
2011-10-28−1,250→ 7,500 total→ Common Stock (1,250 underlying) - Sale
Common Stock
2011-10-28$23.70/sh−413$9,788→ 1,674 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 9, 2011.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock
- [F3]Executive was granted a time-based restricted stock unit award of 10,000 shares of common stock of the Company on April 25, 2011, and vesting in equal installments on a quarterly basis over a period of twenty-four months.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001519023
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:19 PM ET
- Size
- 8.9 KB